Trial Identifier: | D3250R00113 |
Sponsor: | AstraZeneca |
NCTID:: | NCT05603845 |
Start Date: | February 2023 |
Primary Completion Date: | March 2025 |
Study Completion Date: | March 2025 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
Country | Location |
---|---|
Brazil, Sao Paulo | São Paulo, Sao Paulo, Brazil, 05403-000 |
Brazil, Sao Paulo | São Paulo, Sao Paulo, Brazil, 05403-000 |
Brazil, Sao Paulo | São Paulo, Sao Paulo, Brazil, 05403-000 |
Brazil, Sao Paulo | São Paulo, Sao Paulo, Brazil, 05403-000 |
Brazil, Sao Paulo | São Paulo, Sao Paulo, Brazil, 05403-000 |
Brazil, Sao Paulo | São Paulo, Sao Paulo, Brazil, 05403-000 |
Brazil, Sao Paulo | São Paulo, Sao Paulo, Brazil, 05403-000 |
Brazil, Sao Paulo | São Paulo, Sao Paulo, Brazil, 05403-000 |
Brazil, Sao Paulo | São Paulo, Sao Paulo, Brazil, 05403-000 |
Brazil, Sao Paulo | São Paulo, Sao Paulo, Brazil, 05403-000 |
Brazil, Sao Paulo | São Paulo, Sao Paulo, Brazil, 05403-000 |
Brazil, Sao Paulo | São Paulo, Sao Paulo, Brazil, 05403-000 |
Brazil, Sao Paulo | São Paulo, Sao Paulo, Brazil, 05403-000 |
Brazil, Sao Paulo | São Paulo, Sao Paulo, Brazil, 05403-000 |
Brazil, Sao Paulo | São Paulo, Sao Paulo, Brazil, 05403-000 |
Brazil, Sao Paulo | São Paulo, Sao Paulo, Brazil, 05403-000 |
Brazil, Sao Paulo | São Paulo, Sao Paulo, Brazil, 05403-000 |
Brazil, Sao Paulo | São Paulo, Sao Paulo, Brazil, 05403-000 |
Brazil, Sao Paulo | São Paulo, Sao Paulo, Brazil, 05403-000 |
Brazil, Sao Paulo | São Paulo, Sao Paulo, Brazil, 05403-000 |
Brazil, Sao Paulo | São Paulo, Sao Paulo, Brazil, 05403-000 |
Brazil, Sao Paulo | São Paulo, Sao Paulo, Brazil, 05403-000 |
Brazil, Sao Paulo | São Paulo, Sao Paulo, Brazil, 05403-000 |
Brazil, Sao Paulo | São Paulo, Sao Paulo, Brazil, 05403-000 |